N

Neal Rosen

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-8307-654X

Publishes on Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies. 1k papers and 55.4k citations.

PubIndex Score98Top 2%How it's scored

🌟#8 Current Senior Leader in Cancer Mechanisms and Therapy

1kPublications

55.4kTotal Citations

#8in Cancer Mechanisms and Therapy

First publication: 1977First senior author: 1987

Melanoma and MAPK Pathways Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies PI3K/AKT/mTOR signaling in cancer Synthesis and biological activity

Top publicationsby citations

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

Kathryn O’Reilly, Neal Rosen|Cancer Research|2006

Cited by 2.5k

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

Poulikos I. Poulikakos, Neal Rosen, Chao Zhang et al.|Nature|2010

Cited by 1.8k

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Poulikos I. Poulikakos, David B. Solit, May Tal Gabay et al.|Nature|2011

Cited by 1.4k

BRAF mutation predicts sensitivity to MEK inhibition

David B. Solit, Neal Rosen, Levi A. Garraway et al.|Nature|2005

Cited by 1.3k

Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

Robin C. Muise‐Helmericks, Neal Rosen, H. Leighton Grimes et al.|Journal of Biological Chemistry|1998

Cited by 512